• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白磷酸酶2A是大脑中主要的酶,可使由脯氨酸定向蛋白激酶或环磷酸腺苷依赖性蛋白激酶磷酸化的tau蛋白去磷酸化。

Protein phosphatase 2A is the major enzyme in brain that dephosphorylates tau protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase.

作者信息

Goedert M, Jakes R, Qi Z, Wang J H, Cohen P

机构信息

MRC Laboratory of Molecular Biology, Cambridge, England, U.K.

出版信息

J Neurochem. 1995 Dec;65(6):2804-7. doi: 10.1046/j.1471-4159.1995.65062804.x.

DOI:10.1046/j.1471-4159.1995.65062804.x
PMID:7595582
Abstract

The paired helical filament (PHF), which makes up the major fibrous component of the neurofibrillary lesions of Alzheimer's disease, is composed of hyperphosphorylated and abnormally phosphorylated microtubule-associated protein tau. Previous studies have identified serine and threonine residues phosphorylated in PHF-tau and have shown that tau can be phosphorylated at several of these sites by proline-directed protein kinases and cyclic AMP-dependent protein kinase. Here we have investigated which protein phosphatase activities can dephosphorylate recombinant tau phosphorylated with mitogen-activated protein kinase, glycogen synthase kinase-3 beta, neuronal cdc2-like kinase, or cyclic AMP-dependent protein kinase. We show that protein phosphatase 2A is by far the major protein phosphatase activity in brain that dephosphorylates tau phosphorylated in this manner.

摘要

成对螺旋丝(PHF)构成了阿尔茨海默病神经原纤维病变的主要纤维成分,它由过度磷酸化和异常磷酸化的微管相关蛋白tau组成。先前的研究已确定了PHF-tau中磷酸化的丝氨酸和苏氨酸残基,并表明tau可在其中几个位点被脯氨酸定向蛋白激酶和环磷酸腺苷依赖性蛋白激酶磷酸化。在此,我们研究了哪些蛋白磷酸酶活性能够使被丝裂原活化蛋白激酶、糖原合酶激酶-3β、神经元细胞周期蛋白依赖性激酶2样激酶或环磷酸腺苷依赖性蛋白激酶磷酸化的重组tau去磷酸化。我们发现,蛋白磷酸酶2A是大脑中使以这种方式磷酸化的tau去磷酸化的主要蛋白磷酸酶活性。

相似文献

1
Protein phosphatase 2A is the major enzyme in brain that dephosphorylates tau protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase.蛋白磷酸酶2A是大脑中主要的酶,可使由脯氨酸定向蛋白激酶或环磷酸腺苷依赖性蛋白激酶磷酸化的tau蛋白去磷酸化。
J Neurochem. 1995 Dec;65(6):2804-7. doi: 10.1046/j.1471-4159.1995.65062804.x.
2
p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease [corrected].微管相关蛋白tau中的p42丝裂原活化蛋白激酶磷酸化位点被蛋白磷酸酶2A1去磷酸化。对阿尔茨海默病的意义[已修正]
FEBS Lett. 1992 Nov 2;312(1):95-9. doi: 10.1016/0014-5793(92)81418-l.
3
Dephosphorylation of abnormal sites of tau factor by protein phosphatases and its implication for Alzheimer's disease.蛋白磷酸酶对tau因子异常位点的去磷酸化作用及其与阿尔茨海默病的关系。
Neurochem Int. 1995 Mar;26(3):205-15. doi: 10.1016/0197-0186(94)00135-h.
4
Dephosphorylation of microtubule-associated protein tau by protein phosphatase-1 and -2C and its implication in Alzheimer disease.蛋白磷酸酶-1和-2C对微管相关蛋白tau的去磷酸化作用及其在阿尔茨海默病中的意义。
FEBS Lett. 1994 Mar 14;341(1):94-8. doi: 10.1016/0014-5793(94)80247-5.
5
Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain.蛋白磷酸酶-2A和-1在大鼠前脑GSK-3、cdk5和cdc2调节及tau蛋白磷酸化中的作用
FEBS Lett. 2000 Nov 17;485(1):87-93. doi: 10.1016/s0014-5793(00)02203-1.
6
Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.糖原合酶激酶-3在转染的哺乳动物细胞中使微管相关蛋白tau发生类似阿尔茨海默病的磷酸化。
Curr Biol. 1994 Dec 1;4(12):1077-86. doi: 10.1016/s0960-9822(00)00246-3.
7
Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A.蛋白磷酸酶2A对阿尔茨海默病异常磷酸化tau蛋白的去磷酸化作用
Neuroscience. 1994 Aug;61(4):765-72. doi: 10.1016/0306-4522(94)90400-6.
8
Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5.异常糖基化可调节蛋白激酶A对tau的磷酸化作用以及蛋白磷酸酶2A和5对tau的去磷酸化作用。
Neuroscience. 2002;115(3):829-37. doi: 10.1016/s0306-4522(02)00510-9.
9
Tau phosphorylation in brain slices: pharmacological evidence for convergent effects of protein phosphatases on tau and mitogen-activated protein kinase.脑片中的tau磷酸化:蛋白磷酸酶对tau和丝裂原活化蛋白激酶的趋同作用的药理学证据。
Mol Pharmacol. 1995 Apr;47(4):745-56.
10
Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments.脑脯氨酸定向蛋白激酶使与阿尔茨海默病配对螺旋丝相关的tau蛋白上异常磷酸化的位点发生磷酸化。
J Biol Chem. 1993 Nov 5;268(31):23512-8.

引用本文的文献

1
Brain-derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia.脑源性tau蛋白用于衡量阿尔茨海默病和额颞叶痴呆的治疗效果。
Alzheimers Dement (Amst). 2025 Jun 5;17(2):e70123. doi: 10.1002/dad2.70123. eCollection 2025 Apr-Jun.
2
Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration.神经退行性变中TDP - 43磷酸化的分子机制及后果
Mol Neurodegener. 2025 May 8;20(1):53. doi: 10.1186/s13024-025-00839-8.
3
The ameliorative potential of metformin against aluminum-induced neurotoxicity: Insights from in vitro studies.
二甲双胍对铝诱导的神经毒性的改善潜力:来自体外研究的见解。
J Appl Toxicol. 2025 Feb;45(2):245-255. doi: 10.1002/jat.4695. Epub 2024 Sep 14.
4
Neuropathogenesis-on-chips for neurodegenerative diseases.神经退行性疾病的类脑芯片研究进展
Nat Commun. 2024 Mar 12;15(1):2219. doi: 10.1038/s41467-024-46554-8.
5
Tau Protein Alterations Induced by Hypobaric Hypoxia Exposure.低气压低氧暴露诱导的 Tau 蛋白改变。
Int J Mol Sci. 2024 Jan 10;25(2):889. doi: 10.3390/ijms25020889.
6
Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer's disease? From preclinical studies to the clinical trials.tau 过度磷酸化的调节是否代表阿尔茨海默病合理的治疗策略?从临床前研究到临床试验。
Mol Psychiatry. 2023 Jun;28(6):2197-2214. doi: 10.1038/s41380-023-02113-z. Epub 2023 Jun 2.
7
Epigallocatechin gallate restores the reduction of protein phosphatase 2 A subunit B caused by middle cerebral artery occlusion.表没食子儿茶素没食子酸酯可恢复大脑中动脉闭塞所致的蛋白磷酸酶2A亚基B的减少。
Lab Anim Res. 2023 Feb 14;39(1):3. doi: 10.1186/s42826-023-00155-6.
8
Sodium selenate as a therapeutic for tauopathies: A hypothesis paper.硒酸钠作为tau蛋白病的一种治疗方法:一篇假说论文。
Front Aging Neurosci. 2022 Aug 5;14:915460. doi: 10.3389/fnagi.2022.915460. eCollection 2022.
9
A phase 1b open-label study of sodium selenate as a disease-modifying treatment for possible behavioral variant frontotemporal dementia.一项关于硒酸钠作为可能的行为变异型额颞叶痴呆疾病修饰治疗的1b期开放标签研究。
Alzheimers Dement (N Y). 2022 May 5;8(1):e12299. doi: 10.1002/trc2.12299. eCollection 2022.
10
Sodium selenate as a disease-modifying treatment for mild-moderate Alzheimer's disease: an open-label extension study.硒酸钠作为轻度至中度阿尔茨海默病的疾病修饰治疗:一项开放标签扩展研究。
BMJ Neurol Open. 2021 Dec 16;3(2):e000223. doi: 10.1136/bmjno-2021-000223. eCollection 2021.